MARIOTTO, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.762
AS - Asia 826
EU - Europa 540
SA - Sud America 239
AF - Africa 117
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.504
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.675
SG - Singapore 294
BR - Brasile 186
CN - Cina 176
HK - Hong Kong 136
IT - Italia 125
DE - Germania 88
FI - Finlandia 49
PL - Polonia 41
VN - Vietnam 37
FR - Francia 30
GB - Regno Unito 30
RU - Federazione Russa 29
IN - India 22
KR - Corea 21
NL - Olanda 21
CA - Canada 20
AT - Austria 12
SE - Svezia 12
UA - Ucraina 12
AR - Argentina 10
MX - Messico 10
TR - Turchia 10
UZ - Uzbekistan 10
ES - Italia 8
GF - Guiana Francese 8
JO - Giordania 8
BJ - Benin 7
EC - Ecuador 7
EE - Estonia 7
GP - Guadalupe 7
JP - Giappone 7
ML - Mali 7
MY - Malesia 7
RO - Romania 7
AE - Emirati Arabi Uniti 6
BD - Bangladesh 6
HN - Honduras 6
LU - Lussemburgo 6
NI - Nicaragua 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
TH - Thailandia 6
TN - Tunisia 6
BF - Burkina Faso 5
CM - Camerun 5
CO - Colombia 5
ET - Etiopia 5
GE - Georgia 5
GR - Grecia 5
LA - Repubblica Popolare Democratica del Laos 5
PY - Paraguay 5
TJ - Tagikistan 5
VE - Venezuela 5
ZA - Sudafrica 5
ZM - Zambia 5
AL - Albania 4
AZ - Azerbaigian 4
BB - Barbados 4
BG - Bulgaria 4
BO - Bolivia 4
BS - Bahamas 4
CL - Cile 4
CV - Capo Verde 4
DK - Danimarca 4
GN - Guinea 4
ID - Indonesia 4
IL - Israele 4
IQ - Iraq 4
IR - Iran 4
IS - Islanda 4
KG - Kirghizistan 4
LV - Lettonia 4
MA - Marocco 4
PA - Panama 4
PE - Perù 4
PH - Filippine 4
PR - Porto Rico 4
PS - Palestinian Territory 4
SN - Senegal 4
AF - Afghanistan, Repubblica islamica di 3
BA - Bosnia-Erzegovina 3
BZ - Belize 3
CR - Costa Rica 3
CU - Cuba 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
EG - Egitto 3
GH - Ghana 3
IE - Irlanda 3
KE - Kenya 3
KH - Cambogia 3
LB - Libano 3
MG - Madagascar 3
MK - Macedonia 3
MU - Mauritius 3
MW - Malawi 3
NP - Nepal 3
PF - Polinesia Francese 3
PG - Papua Nuova Guinea 3
Totale 3.406
Salva come PNG Salva come JPEG
Città #
Fairfield 209
Ashburn 204
Singapore 194
Hong Kong 135
Chandler 114
Woodbridge 112
Seattle 103
Cambridge 91
Santa Clara 86
Houston 85
Ann Arbor 68
Wilmington 61
Beijing 53
Munich 47
Boardman 39
Bytom 31
San Diego 31
Hefei 26
Padova 26
Des Moines 24
Helsinki 24
Medford 24
Princeton 24
Roxbury 20
Turku 16
Seoul 15
London 11
Los Angeles 11
São Paulo 11
Ho Chi Minh City 10
Dong Ket 9
Jinan 9
North York 9
Tashkent 9
Amman 8
Council Bluffs 8
Vienna 8
Bamako 7
Hanoi 7
Nanjing 7
Belo Horizonte 6
Cagliari 6
Chicago 6
Falls Church 6
Lappeenranta 6
Managua 6
New York 6
Ogden 6
Addis Ababa 5
Boston 5
Buffalo 5
Cayenne 5
Cotonou 5
Les Abymes 5
Lusaka 5
Ouagadougou 5
Toronto 5
Anagni 4
Auckland 4
Baku 4
Bishkek 4
Brasília 4
Bridgetown 4
Conakry 4
Dakar 4
Dushanbe 4
Guangzhou 4
Guayaquil 4
Hebei 4
Luxembourg 4
Milan 4
Nassau 4
Panama City 4
Phoenix 4
Porto Alegre 4
Rovigo 4
Shanghai 4
Shenyang 4
Tallinn 4
The Dalles 4
Tirana 4
Tokyo 4
Accra 3
Antananarivo 3
Aracaju 3
Bangkok 3
Calvisano 3
Campinas 3
Caracas 3
Charlotte 3
Chennai 3
Ciudad del Este 3
Curitiba 3
Dallas 3
Desio 3
Dili 3
Dublin 3
Falkenstein 3
Hangzhou 3
Ipatinga 3
Totale 2.233
Salva come PNG Salva come JPEG
Nome #
AKR1C enzymes sustain therapy resistance in paediatric T-ALL 194
Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2- d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors 178
EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells 171
Choline kinase alpha inhibition by EB-3D triggers cellular senescence, reduces tumor growth and metastatic dissemination in breast cancer 170
Lead optimization-hit expansion of new asymmetrical pyridinium/quinolinium compounds as choline kinase α1 inhibitors 148
SYK targeting represents a potential therapeutic option for relapsed resistant pediatric ETV6-RUNX1 B-acute lymphoblastic leukemia patients 144
TP-0903 inhibits neuroblastoma cell growth and enhances the sensitivity to conventional chemotherapy 143
A BAG's life: Every connection matters in cancer 122
New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1 112
Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems 112
Design, synthesis, in vitro and in vivo biological evaluation of 2-amino-3-aroylbenzo[b]furan derivatives as highly potent tubulin polymerization inhibitors 111
Design, synthesis and biological evaluation of novel vicinal diaryl-substituted 1H-Pyrazole analogues of combretastatin A-4 as highly potent tubulin polymerization inhibitors 106
Autophagic flux inhibition enhances cytotoxicity of the receptor tyrosine kinase inhibitor ponatinib 106
In vitro and in vivo antitumor activity of new choline kinase inhibitor: a pharmacological strategy for breast cancer and leukemia treatment. 106
Design and synthesis of potent in vitro and in vivo anticancer agents based on 1-(3',4',5'-trimethoxyphenyl)-2-Aryl-1H-imidazole 105
A facile synthesis of diaryl pyrroles led to the discovery of potent colchicine site antimitotic agents 103
Cinnamic acid derivatives linked to arylpiperazines as novel potent inhibitors of tyrosinase activity and melanin synthesis 97
Design, Synthesis and Biological Investigation of 2-Anilino Triazolopyrimidines as Tubulin Polymerization Inhibitors with Anticancer Activities 94
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents 90
BAG1 down-regulation increases chemo-sensitivity of acute lymphoblastic leukaemia cells 90
Design, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1) 89
Design, synthesis and biological evaluation of novel 2,4-thiazolidinedione derivatives able to target the human BAG3 protein 87
Synthesis and Biological Evaluation of Highly Active 7-Anilino Triazolopyrimidines as Potent Antimicrotubule Agents 85
Identification of Homoharringtonine as a potent inhibitor of glioblastoma cell proliferation and migration 84
Histone Deacetylase Inhibitors Impair Glioblastoma Cell Motility and Proliferation 83
Anticancer and structure activity relationship of non-symmetrical choline kinase inhibitors 82
Design, Synthesis and Biological Investigation of 2-Anilino Triazolopyrimidines as Tubulin Polymerization Inhibitors with Anticancer Activities 78
Synthesis, biological evaluation, in silico modeling and crystallization of novel small monocationic molecules with potent antiproliferative activity by dual mechanism 76
Molecular and functional profiling of chemotolerant cells unveils nucleoside metabolism-dependent vulnerabilities in medulloblastoma 75
Biological Evaluation of New Thienopyridinium and Thienopyrimidinium Derivatives as Human Choline Kinase Inhibitors 74
Synthesis and Biological Evaluation of Novel 2-Aroyl Benzofuran-Based Hydroxamic Acids as Antimicrotubule Agents 67
New bioisosteric sulphur-containing choline kinase inhibitors with a tracked mode of action 62
New bioisosteric sulphur-containing choline kinase inhibitors with a tracked mode of action 60
Potent In Vitro and In Vivo Anticancer Activity of New Bipyridine and Bipyrimidine Gold (III) Dithiocarbamate Derivatives 30
HLA Class II Antibody Activation of Endothelial Cells Promotes Th17 and Disrupts Regulatory T Lymphocyte Expansion 29
Totale 3.563
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.032
article - articoli 13.654
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.686
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021256 0 0 17 39 11 10 6 21 40 30 47 35
2021/2022360 1 7 69 15 21 20 30 46 20 22 41 68
2022/2023272 48 21 2 34 31 42 4 19 30 15 22 4
2023/2024211 5 39 27 25 17 7 19 9 8 16 17 22
2024/20251.129 6 112 39 49 138 31 98 111 83 42 163 257
2025/2026818 271 281 266 0 0 0 0 0 0 0 0 0
Totale 3.563